Showing results (51-60 of 141) with videos related to
Sort By:
Pageof 15
The British Journal of Dermatology|September 22, 2010
Analysis of cytokine secretion from lymphocytes of patients with hypersensitivity reactions to contaminated heparinsM Martin, H Ott, H F Merk, et al.The British Journal of Dermatology|June 1, 1993
Selective generation of CD8+ T-cell clones from the peripheral blood of patients with cutaneous reactions to beta-lactam antibioticsM Hertl, J Geisel, C Boecker, et al.Skin Pharmacology and Applied Skin Physiology|November 30, 2000
New insights into the pathomechanisms of contact dermatitis by the use of transgenic mouse modelsC Traidl, H F Merk, A Cavani, et al.Allergy|February 13, 2001
Molecular features determining lymphocyte reactivity in allergic contact dermatitis to chloramphenicol and azidamphenicolB Sachs, S Erdmann, T al Masaoudi, et al.European Journal of Dermatology : EJD|May 20, 2006
The porphyrias: clinical presentation, diagnosis and treatmentP Poblete-Gutiérrez, T Wiederholt, H F Merk, et al.Der Hautarzt; Zeitschrift Fur Dermatologie, Venerologie, Und Verwandte Gebiete|April 16, 2009
[Contact sensitization to azole antimycotics]R Brans, M Wosnitza, J M Baron, et al.American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|May 31, 2001
Comparison of patch test results with a standard series among white and black racial groupsH Dickel, J S Taylor, P Evey, et al.American Journal of Contact Dermatitis : Official Journal of the American Contact Dermatitis Society|December 21, 2000
Delayed readings of a standard screening patch test tray: frequency of "lost," "found," and "persistent" reactionsH Dickel, J S Taylor, P Evey, et al.The British Journal of Dermatology|March 17, 2001
In vitro drug allergy detection system incorporating human liver microsomes in chlorazepate-induced skin rash: drug-specific proliferation associated with interleukin-5 secretionB Sachs, S Erdmann, T Al-Masaoudi, et al.Current Medicinal Chemistry. Anti-Cancer Agents|October 8, 2003
Current and future directions in the treatment of metastatic malignant melanomaJ M Baron, R Heise, H F Merk, et al.Pageof 15